Accendra Health, Inc. (ACH) is currently priced at $3.56, marking a 3.95% increase since the previous close. With a trading volume of $133,671, 15.28% higher than average, ACH demonstrates active investor interest.
The company reports a net cash increase of $249.15 million, ending the period with $281.99 million in cash. Operating cash flow stands at $68.19 million, while debt repayment amounted to $67.2 million.
ACH generated $708.97 million in revenue, yielding a gross profit of $290.29 million. Operating income reached $22 million, despite a net income of -$56.33 million. Notably, the company reported an EPS and EPS diluted of -73 cents.
Key ratios indicate challenges for ACH, with negative net profit margin (-7.94%) and pretax profit margin (-1.12%). The return on equity stands at 12.22%, while the debt-equity ratio is significantly negative at -484.57.
The balance sheet reveals total assets of $2.45 billion, with cash and cash equivalents totaling $281.99 million. Total liabilities amount to $2.91 billion, with net debt standing at $1.95 billion.
This comprehensive analysis sheds light on Accendra Health, Inc.'s financial status, highlighting both strengths and areas for improvement.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.